Press Release November 02, 2022

Novo Holdings Acquires KabaFusion

The Healthcare Private Equity team advised Novo Holdings on its acquisition of KabaFusion from Pritzker Private Capital.

Novo Holdings is a leading international healthcare and life sciences investor wholly owned by the Novo Nordisk Foundation.

KabaFusion is a national provider of essential acute, chronic, and enteral home infusion therapies, licensed to serve patients in 44 states through its nationwide network of home infusion pharmacies and home health agencies.

Pritzker Private Capital partners with middle-market companies based in North America with leading positions in the manufactured products and services sectors.

The Goodwin team was led by Matthew MauneyAndrew Kimball, James Hutchinson, and Taylor Randazzo.

For more details, read the press release